TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

NEOSPHERE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

NEOSPHERE

ST13

US500000097489090

Classe

42

Pedido

97489090

Registro

7989273

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

25

Atualização mais recente

22/10/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

42

Data de depósito

05/07/2022

Data de registro

21/10/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

21/10/2025

Última transação

22/10/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Foreign priority

Código do desenho

4

Tipo de titular

16

Localização do titular

Planegg, DE

Examinador

KLUWE,CHERYL D

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

NEOsphere Biotechnologies GmbH

Representantes

Leo M. Loughlin ROTHWELL, FIGG, ERNST & MANBECK, PC

Classificação técnica

Classes Nice

Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 42

Analysis in the field of molecular biology; Consultancy relating to pharmaceutical research and development; Consultancy in the field of pharmaceutical research; Pharmaceutical product evaluation; Biochemistry research services; Biochemical analysis; Biochemistry services in the nature of mass spectrometry based proteomics and proteomic data analysis; Biochemical research and analysis; Biological analysis; Biological research and development services; Biological research; Biological research and analysis; Biological research, clinical research and medical research; Biomedical research services; Biotechnological research relating to industry; Research relating to biotechnology; Computer programming in the medical field; Computer software programming services; Medical research laboratory services; Biological research laboratory services; Services for assessing the efficiency of pharmaceuticals being testing of pharmaceuticals; Biotechnology testing; Analysis of human serum for medical research; Analysis of human tissues for medical research; Conducting of scientific studies and research in the field of targeted protein degradation and targeted protein stabilization and related data analysis; Development of pharmaceutical drug preparations and medicines; Development and creation of computer programmes for data processing; Computer software development for others; Development of data bases; Pharmaceutical products development; computer software development; Design and development of data processing programs; Research and development of vaccines and medicines; Research relating to molecular sciences; Research on the subject of pharmaceuticals; Research and development services in the field of immunology; Research and development in the pharmaceutical and biotechnology fields; Biochemical research and development; Research and development for the pharmaceutical industry; Research and development in the field of microorganisms and cells; Clinical research in the field of targeted protein degradation and targeted protein stabilization and related data analysis; Medical and scientific research, namely, conducting clinical trials for others; Laboratory research services relating to pharmaceuticals; Medical research; Medical research in the field of oncology; Pharmaceutical drug development services; Pharmaceutical research services; Pharmaceutical research and development; Preparation of biological samples for research purposes; Preparation of biological samples for analysis in research laboratories; Preparation of biological samples for testing and analysis in research laboratories; Scientific and technological services, namely, scientific analysis in the field of targeted protein degradation and targeted protein stabilization and related data analysis; Scientific research in the field of drug discovery; Scientific research relating to biology; Scientific research and development; Scientific research for medical purposes in the area of cancerous diseases; Scientific investigations for medical purposes

Publicações

Histórico de despachos e eventos da marca no USPTO.

25 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

21/10/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

21/10/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/09/2025

PUBO

PUBLISHED FOR OPPOSITION

02/09/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

27/08/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

28/07/2025

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

21/05/2025

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

20/11/2024

DOCK

ASSIGNED TO EXAMINER

30/08/2024

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

16/02/2024

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

16/08/2023

GNSL

LETTER OF SUSPENSION E-MAILED

16/08/2023

CNSL

SUSPENSION LETTER WRITTEN

16/08/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

20/07/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

19/07/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

19/07/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

24/04/2023

GNRT

NON-FINAL ACTION E-MAILED

24/04/2023

CNRT

NON-FINAL ACTION WRITTEN

24/04/2023

DOCK

ASSIGNED TO EXAMINER

19/04/2023

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

11/10/2022

ALIE

ASSIGNED TO LIE

11/10/2022

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

31/08/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

25/07/2022

NWAP

NEW APPLICATION ENTERED

08/07/2022

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace NEOSPHERE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.